ChemicalBook >> CAS DataBase List >>PRT-060318

PRT-060318

CAS No.
1194961-19-7
Chemical Name:
PRT-060318
Synonyms
CS-1688;PRT 318;P 142-76;PRT-060318;PRT-060318 ≥95%;PRT-060318(PRT318);PRT 060318 ;PRT060318;PRT 318;PRT-318;PRT318;2-(((1R,2S)-2-aminocyclohexyl)amino)-4-(m-tolylamino)pyrimidine-5-carboxamide;4-(3-methyl-phenyl-amino-)-2-(2-amino-cyclo-hexyl-amino-)-pyrimidine-5-carboxamide;2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[(3-methylphenyl)amino]-5-pyrimidinecarboxamide
CBNumber:
CB12731127
Molecular Formula:
C18H24N6O
Molecular Weight:
340.42
MDL Number:
MFCD28155088
MOL File:
1194961-19-7.mol
Last updated:2023-09-04 15:50:00

PRT-060318 Properties

Melting point 152 - 155°C
Boiling point 602.1±65.0 °C(Predicted)
Density 1.277±0.06 g/cm3(Predicted)
storage temp. Refrigerator, under inert atmosphere
solubility DMSO (Slightly), Methanol (Slightly)
form Solid
pka 14.10±0.50(Predicted)
color Pale Brown

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS02
Signal word  Danger
Hazard statements  H242
Precautionary statements  P210-P234-P235-P240-P370+P378-P403

PRT-060318 price More Price(29)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich SML2505 PRT-060318 ≥95% (HPLC) 1194961-19-7 5mg $123 2024-03-01 Buy
Sigma-Aldrich SML2505 PRT-060318 ≥95% (HPLC) 1194961-19-7 25mg $347 2024-03-01 Buy
Cayman Chemical 22476 PRT060318 ≥98% 1194961-19-7 5mg $144 2024-03-01 Buy
Cayman Chemical 22476 PRT060318 ≥98% 1194961-19-7 10mg $274 2024-03-01 Buy
Cayman Chemical 22476 PRT060318 ≥98% 1194961-19-7 25mg $502 2024-03-01 Buy
Product number Packaging Price Buy
SML2505 5mg $123 Buy
SML2505 25mg $347 Buy
22476 5mg $144 Buy
22476 10mg $274 Buy
22476 25mg $502 Buy

PRT-060318 Chemical Properties,Uses,Production

Description

PRT060318 is a potent and selective inhibitor of spleen tyrosine kinase (Syk; IC50 = 4 nM). It is selective, inhibiting 92% of Syk activity, while other kinases retain >70% activity, at a concentration of 50 nM in a panel of 270 kinases. PRT060318 inhibits convulxin-induced aggregation of human platelet-rich plasma (IC50 = 2.5 μM) in vitro and prevents thrombosis in a transgenic mouse model of heparin-induced thrombocytopenia. It induces chronic lymphocytic leukemia (CLL) B cell apoptosis and inhibits the secretion of chemokines CCL3, CCL4, and CXCL13. PRT060318 also inhibits CLL B cell chemotaxis and pseudoemperipolesis.

Uses

PRT 060318 is a novel selective inhibitor of the tyrosine kinase Syk. PRT 060318 may be used in Heparin-Induced Thrombocytopenia (HIT) treatment. HIT is a major cause of morbidity and mortality.

in vitro

prt-060318 was identified as a potent inhibitor of purified syk kinase. syk kinase was inhibited by 92%, while the activities all other kinases retained more than 70% when prt-060318 were evaluated at a concentration of 50 nm in a broad panel of kinase enzyme assays. in addition, prt-060318 could dose-responsively inhibited convulxin-induced human prp aggregation. moreover, it was found that prt-060318 was able to dose-responsively inhibit the increases in intracellular calcium in convulxin-treated platelets [1].

in vivo

animal study showed that in contrast to vehicle-treated mice developed the expected thrombocytopenia, prt-060318-treated mice had no significant change in platelet counts after injection of heparin. moreover, the nadir platelet counts of prt-060318-treated mice were found to be significantly higher than control mice. the prt-060318-treated mice showed no bleeding diathesis or other adverse effects. in addition, prt-060318 treatment in crush thrombosis model resulted in significant inhibition of platelet deposition without changing bleeding time [1].

IC 50

4 nm

References

[1] reilly mp,sinha u,andré p,taylor sm,pak y,deguzman fr,nanda n,pandey a,stolla m,bergmeier w,mckenzie se. prt-060318, a novel syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model. blood.2011 feb 17;117(7):2241-6.

PRT-060318 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 73)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32715 60
Career Henan Chemica Co
+86-0371-86658258 15093356674; laboratory@coreychem.com China 30255 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10523 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6393 58
Hangzhou MolCore BioPharmatech Co.,Ltd.
+86-057181025280; +8617767106207 sales@molcore.com China 49739 58
TargetMol Chemicals Inc.
+1-781-999-5354 support@targetmol.com United States 19973 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054 trendseenbio@gmail.com China 11681 58
LEAPCHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 43348 58
Aladdin Scientific
+1-+1(833)-552-7181 sales@aladdinsci.com United States 57511 58
Amadis Chemical Company Limited
571-89925085 sales@amadischem.com China 131980 58

PRT-060318 Spectrum

1194961-19-7(PRT-060318)Related Search:

PRT-060318 PRT-060318(PRT318) 2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[(3-methylphenyl)amino]-5-pyrimidinecarboxamide P 142-76 PRT 318 2-(((1R,2S)-2-aminocyclohexyl)amino)-4-(m-tolylamino)pyrimidine-5-carboxamide CS-1688 PRT-060318 ≥95% PRT 060318 ;PRT060318;PRT 318;PRT-318;PRT318 5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[(3-methylphenyl)amino]- 4-(3-methyl-phenyl-amino-)-2-(2-amino-cyclo-hexyl-amino-)-pyrimidine-5-carboxamide 1194961-19-7 C18H27Cl3N6O